-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KQvEg1n1oOy9sSCbNnxrWYYx1cODEzx1zb9ZjJW1zKw+I52/I5Ijs0R9Bx1TvRct
 A1X1m/rHL9c4Xnj/S6Tu9w==

<SEC-DOCUMENT>0001003124-08-000001.txt : 20080125
<SEC-HEADER>0001003124-08-000001.hdr.sgml : 20080125
<ACCEPTANCE-DATETIME>20080125095623
ACCESSION NUMBER:		0001003124-08-000001
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070518
FILED AS OF DATE:		20080125
DATE AS OF CHANGE:		20080125

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PHARMACEUTICAL PRODUCT DEVELOPMENT INC
		CENTRAL INDEX KEY:			0001003124
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				561640186
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		929 NORTH FRONT STREET
		CITY:			WILMINGTON
		STATE:			NC
		ZIP:			28401
		BUSINESS PHONE:		9102510081

	MAIL ADDRESS:	
		STREET 1:		929 NORTH FRONT STREET
		CITY:			WILMINGTON
		STATE:			NC
		ZIP:			28401

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BADDOUR LINDA
		CENTRAL INDEX KEY:			0001181151

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27570
		FILM NUMBER:		08549412

	BUSINESS ADDRESS:	
		STREET 1:		PHARMACEUTICAL PRODUCT DEVELOPMENT INC
		STREET 2:		3151 S 17TH ST
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			28412
		BUSINESS PHONE:		7034646300

	MAIL ADDRESS:	
		STREET 1:		PRA INTERNATIONAL
		STREET 2:		12120 SUNSET HILLS ROAD, SUITE 600
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2007-05-18</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0001003124</issuerCik>
        <issuerName>PHARMACEUTICAL PRODUCT DEVELOPMENT INC</issuerName>
        <issuerTradingSymbol>PPDI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001181151</rptOwnerCik>
            <rptOwnerName>BADDOUR LINDA</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PPD, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>929 NORTH FRONT STREET</rptOwnerStreet2>
            <rptOwnerCity>WILMINGTON</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>28401</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Former Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2007-05-18</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>5943</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>34.94</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>22057</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">As permitted under the terms of the Issuer's Equity Compensation Plan, this represents a disposition of shares to the Issuer to fund the Reporting Person's tax withholding obligation relating to the vesting on 05/18/2007 of 14,000 shares of restricted stock originally granted on 05/18/2005.</footnote>
    </footnotes>

    <remarks>Ms. Baddour ceased being a reporting person of the Issuer on May 31, 2007.</remarks>

    <ownerSignature>
        <signatureName>Lisa C. Noeker, attorney in fact for Linda Baddour</signatureName>
        <signatureDate>2008-01-25</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----